CARTESIAN THERAPEUTICS INC
RNACNASDAQ๐ #3592 by market capEarnings Nov 4US Equity
$6.75โฒ $0.06 (+0.90%)
๐ After hours$6.75โฒ 0.00%Regular close ยท extended-hours price shownTrack RNAC
Get earnings, price moves & breaking news on Telegram
24hโฒ 0.9%
7dโฒ 9.0%
14dโฒ 7.7%
30dโผ 6.9%
ytdโผ 6.2%
1yโผ 16.7%
๐ฆMarket Cap
$204M
Small Cap
๐Revenue Growth (YoY)
-20.7%
Declining
๐Gross Margin
โ
๐ตFCF Margin
422.1%
Strong
โ๏ธP/S Ratio
115.6x
Expensive
Otter Score
โ
Insufficient data
CARTESIAN THERAPEUTICS INC
RNACAnalyst Ratings
Price
$6.75
Total
10
Raised
2
Lowered
2
Avg PT
$25.00
H / L
$25 / $25
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-30 | โ | โ |
Needham | Reiterated | Buy | 2026-09-29 | โ | โ |
Wedbush | Reiterated | Outperform | 2026-08-18 | โ | โ |
BTIG | Reiterated | Buy | 2026-06-09 | โ | โ |
Cantor Fitzgerald | Upgraded | Neutral โ Overweight | 2026-03-09 | $16.00 | +137.00% |
Canaccord Genuity | Reiterated | Buy | 2024-07-03 | $43.00 | +537.00% |
Oppenheimer | Downgraded | Outperform โ Peer Perform | 2024-07-02 | โ | โ |
SVB Leerink | Downgraded | Outperform โ Market Perform | 2023-08-18 | โ | โ |
Mizuho | Reiterated | Buy | 2023-08-18 | โ | โ |
William Blair | Upgraded | Market Perform โ Outperform | 2021-03-12 | โ | โ |
Institution
HC Wainwright & Co.
Reiterated ยท Buy ยท 2026-09-30
โ
โ
Needham
Reiterated ยท Buy ยท 2026-09-29
โ
โ
Wedbush
Reiterated ยท Outperform ยท 2026-08-18
โ
โ
BTIG
Reiterated ยท Buy ยท 2026-06-09
โ
โ
Cantor Fitzgerald
Upgraded ยท Neutral โ Overweight ยท 2026-03-09
$16.00
+137.00%
Canaccord Genuity
Reiterated ยท Buy ยท 2024-07-03
$43.00
+537.00%
Oppenheimer
Downgraded ยท Outperform โ Peer Perform ยท 2024-07-02
โ
โ
SVB Leerink
Downgraded ยท Outperform โ Market Perform ยท 2023-08-18
โ
โ
Mizuho
Reiterated ยท Buy ยท 2023-08-18
โ
โ
William Blair
Upgraded ยท Market Perform โ Outperform ยท 2021-03-12
โ
โ
One row per institution ยท price target from the firm's latest published target